{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:03:36Z","timestamp":1778087016453,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.amjcard.2018.12.020","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T11:35:29Z","timestamp":1545132929000},"page":"905-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Usefulness of Triiodothyronine Replacement Therapy in Patients With ST Elevation Myocardial Infarction and Borderline\/Reduced Triiodothyronine Levels (from the THIRST Study)"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-184X","authenticated-orcid":false,"given":"Alessandro","family":"Pingitore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mastorci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-9161","authenticated-orcid":false,"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Donato","family":"Aquaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Ravani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Trianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudina","family":"Ndreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Vassalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.12.020_bib0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.109.917922","article-title":"Thyroid replacement therapy and heart failure","volume":"122","author":"Gerdes","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0002-9343(01)00980-9","article-title":"Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction","volume":"111","author":"Friberg","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0003","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjmed.2004.07.052","article-title":"Triiodothyronine levels for risk stratification of patients with chronic heart failure","volume":"118","author":"Pingitore","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0004","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archinte.162.12.1388","article-title":"Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina","volume":"162","author":"Friberg","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/aps.2011.118","article-title":"Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5603\/CJ.a2013.0108","article-title":"Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention","volume":"21","author":"Ozcan","year":"2014","journal-title":"Cardiol J"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/1010-7940(89)90092-4","article-title":"Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery","volume":"3","author":"Novitzky","year":"1989","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-9343(96)00281-1","article-title":"Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy","volume":"101","author":"Moruzzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0002-9149(97)00950-8","article-title":"Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure","volume":"81","author":"Hamilton","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0011","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1210\/jc.2007-2210","article-title":"Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study","volume":"93","author":"Pingitore","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00395-008-0758-4","article-title":"Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?","volume":"104","author":"Pantos","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2007.09.009","article-title":"Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats","volume":"44","author":"Chen","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0014","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1210\/en.2014-1106","article-title":"Triiodothyronine prevents cardiac ischemia\/reperfusion mitochondrial impairment and cell loss by regulating miR30a\/p53 axis","volume":"155","author":"Forini","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10495-015-1204-3","article-title":"Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction","volume":"21","author":"de Castro","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0016","first-page":"E715","article-title":"Thyroidal and peripheral production of 3,5,3\u2032-triiodothyronine in humans by multicompartmental analysis","volume":"258","author":"Pilo","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0017","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2011-1329","article-title":"Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine","volume":"96","author":"Celi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cardfail.2008.08.008","article-title":"Prognostic value of combined measurement of brain natriuretic peptide and triidothyronine in heart failure","volume":"15","author":"Passino","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0019","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/jmri.25450","article-title":"Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor study","volume":"45","author":"Aquaro","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/eurheartj\/ehs037","article-title":"Scar extent, left ventricular end-diastolic volume, and wall motion abnormalities identify high-risk patients with previous myocardial infarction: a multiparametric approach for prognosis","volume":"34","author":"Di Bella","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0021","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.CIR.98.11.1078","article-title":"Prognostic value of myocardial viability in medically treated patients with global left vetnricular dysfunction early after an acute myocardial uncomplicated myocardial infarction: a dobutamine stress echocardiography study","volume":"98","author":"Picano","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9149(98)00241-0","article-title":"Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction","volume":"82","author":"Fath-Ordoubadi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0023","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1152\/ajpendo.2000.279.6.E1319","article-title":"Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat","volume":"279","author":"Ojamaa","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCHEARTFAILURE.108.810747","article-title":"Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure","volume":"2","author":"KK1","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/EJE-11-0062","article-title":"Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association?","volume":"165","author":"Lymvaios","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0026","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11010-011-1175-9","article-title":"Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: potential involvement of Akt and ERK signaling","volume":"363","author":"Mourouzis","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0027","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.1972.03200070084015","article-title":"The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group","volume":"220","author":"Stamler","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0028","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/clpt.1984.257","article-title":"L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect","volume":"36","author":"Jr","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2018.12.020_bib0029","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2119\/molmed.2015.00140","article-title":"Early and short term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-\u03b21 and anti-fibrotic miRNA signaling","volume":"21","author":"Nicolini","year":"2016","journal-title":"Mol Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918322100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918322100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T12:00:19Z","timestamp":1573560019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918322100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0002914918322100"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Triiodothyronine Replacement Therapy in Patients With ST Elevation Myocardial Infarction and Borderline\/Reduced Triiodothyronine Levels (from the THIRST Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}